Xiaochun Wang
Baoding, 071000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting viral proteins using insulin-like growth factor 2-fused lysosomal targeting chimera platform to combat viral infection.
Journal: International journal of biological macromolecules
Published: June 01, 2026
The degradation revolution: harnessing targeted protein degradation for the treatment of human diseases.
Journal: Cellular and molecular life sciences : CMLS
Published: October 18, 2025
Postoperative exercise rehabilitation and patient experience among breast cancer survivors under the "Healthy China" initiative: an integrative review.
Journal: Frontiers in psychology
Published: August 12, 2025
Efficacy, safety, and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multicenter retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: May 28, 2025
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.
Journal: Breast cancer research : BCR
Published: December 04, 2024
Deubiquitinase OTUD7B Regulates Cell Proliferation in Breast Cancer.
Journal: Clinical breast cancer
Published: June 13, 2024
Molecular Mechanisms Behind Vascular Mimicry as the Target for Improved Breast Cancer Management.
Journal: International journal of women's health
Published: January 29, 2023
Biomimetic Platform Based on Mesoporous Platinum for Multisynergistic Cancer Therapy.
Journal: ACS biomaterials science & engineering
Published: October 12, 2021
Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
Journal: Journal of biomedical science
Published: April 26, 2021
CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
Journal: Journal of biomedical science
Published: July 28, 2020
MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Journal: Archives of biochemistry and biophysics
Published: July 23, 2018
Last Updated: 09/26/2026